Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

Related Citations for PubMed (Select 18773903)

1.

The early use of immunosuppression reduces morbidity in patients with moderately severe or severe Crohn's disease.

Shergill AK, Terdiman JP.

Gastroenterology. 2008 Oct;135(4):1417-20. doi: 10.1053/j.gastro.2008.08.016. Epub 2008 Sep 4. No abstract available.

PMID:
18773903
2.

Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.

Thia KT, Sandborn WJ, Lewis JD, Loftus EV Jr, Feagan BG, Steinhart AH, Hanauer SB, Persson T, Sands BE.

Am J Gastroenterol. 2008 Dec;103(12):3123-31. doi: 10.1111/j.1572-0241.2008.02176.x.

PMID:
18786111
3.

Defective IL-10 production in severe phenotypes of Crohn's disease.

Correa I, Veny M, Esteller M, Piqué JM, Yagüe J, Panés J, Salas A.

J Leukoc Biol. 2009 May;85(5):896-903. doi: 10.1189/jlb.1108698. Epub 2009 Feb 23.

4.

A 5-year prospective observational study of the outcomes of international treatment guidelines for Crohn's disease.

Cullen G, Keegan D, Mulcahy HE, O'Donoghue DP.

Clin Gastroenterol Hepatol. 2009 Mar;7(3):323-8; quiz 252. doi: 10.1016/j.cgh.2008.10.018. Epub 2008 Oct 30.

PMID:
19174193
5.

Impact of complex Crohn's disease on the outcome of laparoscopic ileocecal resection: a comparative clinical study in 124 patients.

Goyer P, Alves A, Bretagnol F, Bouhnik Y, Valleur P, Panis Y.

Dis Colon Rectum. 2009 Feb;52(2):205-10. doi: 10.1007/DCR.0b013e31819c9c08.

PMID:
19279413
6.

Perineal Crohn's disease: an indicator of poor prognosis and potential proctectomy.

Figg RE, Church JM.

Dis Colon Rectum. 2009 Apr;52(4):646-50. doi: 10.1007/DCR.0b013e3181a0a5bf.

PMID:
19404069
7.

Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.

Weersma RK, Stokkers PC, van Bodegraven AA, van Hogezand RA, Verspaget HW, de Jong DJ, van der Woude CJ, Oldenburg B, Linskens RK, Festen EA, van der Steege G, Hommes DW, Crusius JB, Wijmenga C, Nolte IM, Dijkstra G; Dutch Initiative on Crohn and Colitis (ICC).

Gut. 2009 Mar;58(3):388-95. doi: 10.1136/gut.2007.144865. Epub 2008 Sep 29.

PMID:
18824555
8.

Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.

Basturk T, Ozagari A, Ozturk T, Kusaslan R, Unsal A.

J Ren Care. 2009 Sep;35(3):147-50. doi: 10.1111/j.1755-6686.2009.00106.x. Review.

PMID:
19689697
9.

Early-life exposures associated with antibiotic use and risk of subsequent Crohn's disease.

Hildebrand H, Malmborg P, Askling J, Ekbom A, Montgomery SM.

Scand J Gastroenterol. 2008 Aug;43(8):961-6.

PMID:
19086166
10.

[Perianal fistulas in Crohn's disease: treatment results at an interdisciplinary unit].

Iesalnieks I, Glass H, Kilger A, Ott C, Klebl F, Agha A, Schlitt HJ, Strauch U.

Chirurg. 2009 Jun;80(6):549-58. doi: 10.1007/s00104-009-1706-z. German.

PMID:
19387561
11.

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

Jones J, Loftus EV Jr, Panaccione R, Chen LS, Peterson S, McConnell J, Baudhuin L, Hanson K, Feagan BG, Harmsen SW, Zinsmeister AR, Helou E, Sandborn WJ.

Clin Gastroenterol Hepatol. 2008 Nov;6(11):1218-24. doi: 10.1016/j.cgh.2008.06.010. Epub 2008 Sep 17.

PMID:
18799360
13.

Differential diagnosis of intestinal Behçet's disease and Crohn's disease by colonoscopic findings.

Lee SK, Kim BK, Kim TI, Kim WH.

Endoscopy. 2009 Jan;41(1):9-16. doi: 10.1055/s-0028-1103481. Epub 2009 Jan 21.

PMID:
19160153
14.

Enteral nutrition improves health-related quality of life in Crohn's disease patients with long disease duration.

Kuriyama M, Kato J, Morimoto N, Fujimoto T, Kono H, Okano N, Miyaike J, Morita T, Okada H, Suzuki S, Yoshioka T, Shiode J, Shiratori Y, Kazuhide Y; Japan West Crohn's Disease Study Group.

Hepatogastroenterology. 2009 Mar-Apr;56(90):321-7.

PMID:
19579591
15.

Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.

Menchén L, Marín-Jiménez I, Arias-Salgado EG, Fontela T, Hernández-Sampelayo P, Rodríguez MC, Butta NV.

Gut. 2009 Jul;58(7):920-8. doi: 10.1136/gut.2008.150318. Epub 2008 Nov 27.

PMID:
19039088
16.

Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease.

Muise AM, Walters TD, Glowacka WK, Griffiths AM, Ngan BY, Lan H, Xu W, Silverberg MS, Rotin D.

Gut. 2009 Aug;58(8):1121-7. doi: 10.1136/gut.2008.175117. Epub 2009 Apr 26.

PMID:
19398441
17.

Mild to moderate Crohn's disease: an evidence-based treatment algorithm.

Wong K, Bressler B.

Drugs. 2008;68(17):2419-25. doi: 10.2165/0003495-200868170-00002. Review.

PMID:
19016571
18.

Paediatric inflammatory bowel disease in New Zealand.

Yap J, Wesley A, Mouat S, Chin S.

N Z Med J. 2008 Oct 3;121(1283):19-34.

PMID:
18841182
19.

Mild to moderate Crohn's disease: still room for step-up therapies?

Bar-Meir S.

Dig Dis. 2009;27(3):347-50. doi: 10.1159/000228572. Epub 2009 Sep 24. Review.

PMID:
19786763
20.

Are we giving biologics too late? The case for early versus late use.

Ricart E, García-Bosch O, Ordás I, Panés J.

World J Gastroenterol. 2008 Sep 28;14(36):5523-7. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk